ZA200703100B - Method and composition for preventing or treating diarrhea - Google Patents

Method and composition for preventing or treating diarrhea

Info

Publication number
ZA200703100B
ZA200703100B ZA2007/03100A ZA200703100A ZA200703100B ZA 200703100 B ZA200703100 B ZA 200703100B ZA 2007/03100 A ZA2007/03100 A ZA 2007/03100A ZA 200703100 A ZA200703100 A ZA 200703100A ZA 200703100 B ZA200703100 B ZA 200703100B
Authority
ZA
South Africa
Prior art keywords
preventing
composition
treating diarrhea
diarrhea
treating
Prior art date
Application number
ZA2007/03100A
Other languages
English (en)
Inventor
Wai Cheuk
Christina Khoo
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Publication of ZA200703100B publication Critical patent/ZA200703100B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/719—Pullulans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/723—Xanthans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/734—Alginic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L25/00—Baseband systems
    • H04L25/02—Details ; arrangements for supplying electrical power along data transmission lines
    • H04L25/03—Shaping networks in transmitter or receiver, e.g. adaptive shaping networks
    • H04L25/03828—Arrangements for spectral shaping; Arrangements for providing signals with specified spectral properties
    • H04L25/03834—Arrangements for spectral shaping; Arrangements for providing signals with specified spectral properties using pulse shaping
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L27/00—Modulated-carrier systems
    • H04L27/18—Phase-modulated carrier systems, i.e. using phase-shift keying
    • H04L27/20—Modulator circuits; Transmitter circuits
    • H04L27/2003—Modulator circuits; Transmitter circuits for continuous phase modulation
    • H04L27/2007—Modulator circuits; Transmitter circuits for continuous phase modulation in which the phase change within each symbol period is constrained
    • H04L27/2017—Modulator circuits; Transmitter circuits for continuous phase modulation in which the phase change within each symbol period is constrained in which the phase changes are non-linear, e.g. generalized and Gaussian minimum shift keying, tamed frequency modulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Physics & Mathematics (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Signal Processing (AREA)
  • Animal Husbandry (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Nonlinear Science (AREA)
  • Power Engineering (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA2007/03100A 2004-09-16 2007-04-16 Method and composition for preventing or treating diarrhea ZA200703100B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/942,397 US8685943B2 (en) 2003-03-12 2004-09-16 Methods for reducing diarrhea in a companion animal
PCT/US2005/033077 WO2006032005A2 (en) 2004-09-16 2005-09-16 Method and composition for preventing or treating diarrhea

Publications (1)

Publication Number Publication Date
ZA200703100B true ZA200703100B (en) 2015-09-30

Family

ID=36060717

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2007/03100A ZA200703100B (en) 2004-09-16 2007-04-16 Method and composition for preventing or treating diarrhea

Country Status (10)

Country Link
US (3) US8685943B2 (enExample)
EP (1) EP1796728A4 (enExample)
JP (1) JP2008513474A (enExample)
CN (2) CN101060861B (enExample)
AU (1) AU2005284784B2 (enExample)
BR (1) BRPI0515376A (enExample)
CA (1) CA2581020C (enExample)
RU (2) RU2563137C2 (enExample)
WO (1) WO2006032005A2 (enExample)
ZA (1) ZA200703100B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102271531A (zh) * 2009-01-06 2011-12-07 雀巢产品技术援助有限公司 果冻食物组合物中的块状物
JP5554350B2 (ja) * 2009-03-11 2014-07-23 ネステク ソシエテ アノニム 具材入り肉汁食品組成物
EP2588544A1 (fr) * 2010-07-02 2013-05-08 Ifremer (Institut Français De Recherche Pour L'Exploitation De La Mer) Exopolysaccharides pour la prévention et la lutte contre la formation de biofilms
EP2797426A1 (en) * 2011-12-29 2014-11-05 Hill's Pet Nutrition, Inc. Compositions and methods for modifying gastrointestinal flora
JP6452616B2 (ja) * 2012-12-04 2019-01-16 ネステク ソシエテ アノニム 擬似ローフ食品組成物
GB201519854D0 (en) * 2015-11-10 2015-12-23 Mars Inc Pet food
CN107296815A (zh) * 2017-06-29 2017-10-27 中国人民解放军第二军医大学 酵母多糖在制备防护急性放射性骨髓损伤药物中的应用
US11622974B2 (en) 2019-01-18 2023-04-11 C.P. Kelco U.S., Inc. Prebiotic composition and its use
RU2740380C1 (ru) * 2019-12-24 2021-01-13 Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) Биоинженерная конструкция на основе бактериального альгината и пробиотических бактерий и способ ее получения
TWI840668B (zh) * 2021-05-13 2024-05-01 陳昭誠 由β-1-4-葡聚醣形成之纖維於製備用於治療腸躁症之組成物之用途

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1501484A (en) * 1975-10-24 1978-02-15 Tate & Lyle Ltd Icing mixture
US4410551A (en) * 1980-05-15 1983-10-18 Ralston Purina Company Gravy forming intermediate moisture pet food
GB8512345D0 (en) * 1985-05-15 1985-06-19 Scras Anti-diarrhea compositions
US4647470A (en) * 1985-11-27 1987-03-03 Merck & Co., Inc. Low-acetyl gellan gum blends
US4822626A (en) * 1987-01-05 1989-04-18 Nabisco Brands, Inc. Coated canine biscuits
GB8710704D0 (en) 1987-05-06 1987-06-10 Mars G B Ltd Edible gels
EP0291228B1 (en) 1987-05-14 1991-08-28 Merck & Co. Inc. Gellan gum/starch blends
JPH01193388A (ja) 1987-10-09 1989-08-03 Agency Of Ind Science & Technol リオトロピック液晶セル
JP2769707B2 (ja) 1988-11-28 1998-06-25 大洋香料株式会社 透明水性ゲル状芳香剤組成物
JP2779963B2 (ja) 1989-02-09 1998-07-23 株式会社林原生物化学研究所 ビフィズス菌増殖促進剤
DE69112260T2 (de) 1990-04-23 1996-04-11 Monsanto Co Gellan-Gummi-Fasern.
IT1248934B (it) 1990-06-01 1995-02-11 Fidia Spa Membrane forate biocompatibili,processi per la loro preparazione,loro impiego come supporto per la crescita in vitro di cellule epiteliali, pelli artificiali cosi' ottenute e loro impiego nei trapianti di pelle
US5079024A (en) * 1990-09-25 1992-01-07 Kraft General Foods, Inc. Method of manufacture of a non-fat cream cheese product
US5158800A (en) * 1991-10-08 1992-10-27 Merck & Co., Inc. Non-sticky, fat-containing confection
JPH0690707A (ja) * 1992-01-06 1994-04-05 Asahi Chem Ind Co Ltd 緩下作用の改善された食物繊維組成物
US5292534A (en) * 1992-03-25 1994-03-08 Valentine Enterprises, Inc. Sustained release composition and method utilizing xanthan gum and an active ingredient
US5419283A (en) * 1992-04-08 1995-05-30 Ciuffo Gatto S.R.L. Animal chew toy of starch material and degradable ethylene copolymer
US5380522A (en) * 1992-08-11 1995-01-10 Day; Charles E. Method for treatment of irritable bowel syndrome
US5372829A (en) * 1993-01-15 1994-12-13 Merck & Co., Inc. Process for preparing low-fat fried food
CA2125914A1 (en) 1993-06-25 1994-12-26 Pharmacia Corporation Oil-coated microparticulated gellan gum
US5339771A (en) * 1993-09-15 1994-08-23 Axelrod Herbert R Animal chew toy containing animal meal
US5571545A (en) * 1994-02-22 1996-11-05 Fuji Oil Company, Limited Hamburger type food material and process of making it
US5616569A (en) * 1994-03-28 1997-04-01 The Iams Company Pet food product containing fermentable fibers and process for treating gastrointestinal disorders
US5534286A (en) 1994-06-01 1996-07-09 Monsanto Company No-fat gellan gum spread
US5456937A (en) * 1994-06-24 1995-10-10 Chalupa; William F. Gellan gum flavor beads
US5596084A (en) * 1994-10-05 1997-01-21 Monsanto Company Alginate gels
JPH08157377A (ja) * 1994-12-02 1996-06-18 Nippon Oil Co Ltd 家畜等の下痢予防・治療剤
JP3836893B2 (ja) * 1995-01-24 2006-10-25 アボットジャパン株式会社 ポリカルボフィルカルシウム含有製剤
US5827526A (en) * 1995-07-11 1998-10-27 Abbott Laboratories Use of indigestible oligosaccharides to prevent gastrointestinal infections and reduce duration of diarrhea in humans
JPH09172980A (ja) * 1995-12-28 1997-07-08 Ajinomoto Co Inc 新規リン酸アミノ酸複合塩及び水溶性高分子を含有する反すう動物用飼料添加組成物
JP3955112B2 (ja) 1996-01-10 2007-08-08 エステー化学株式会社 ゲル状脱臭剤
JPH09194393A (ja) * 1996-01-22 1997-07-29 Meiji Milk Prod Co Ltd 免疫寛容を誘導する方法、免疫寛容誘導食品キットおよび免疫寛容誘導剤キット
JPH09201170A (ja) 1996-01-24 1997-08-05 Dainippon Pharmaceut Co Ltd ジェランガム含有α化澱粉
JPH09275973A (ja) 1996-04-12 1997-10-28 Suzuki Motor Corp 微生物用培地
GB2314840B (en) 1996-06-28 2000-09-06 Johnson & Johnson Medical Oxidized oligosaccharides and pharmaceutical compositions
JPH1067625A (ja) 1996-08-22 1998-03-10 Lion Corp 口腔用組成物
JPH10179050A (ja) 1996-12-27 1998-07-07 Sanei Gen F F I Inc ネイティブジェランガムを含有する食品
US6458404B1 (en) * 1996-08-27 2002-10-01 San-Ei Gen F.F.I., Inc. Dehydrated gel composition from hydrated isolated acetylated gellan gum
US5869118A (en) * 1996-11-13 1999-02-09 Abbott Laboratories Gellan gum to improve physical stability of liquid nutritional products
US5895804A (en) * 1997-10-27 1999-04-20 National Starch And Chemical Investment Holding Corporation Thermosetting polysaccharides
JP3874560B2 (ja) 1998-01-09 2007-01-31 旭化成ケミカルズ株式会社 微細セルロース含有複合物
TW408153B (en) 1998-01-09 2000-10-11 Asahi Chemical Ind Cellulose-containing composite, process for its preparation and use thereof
JP2002517568A (ja) 1998-06-10 2002-06-18 モンサント・ピーエルシー 改質ゲランガム組成物、その調製工程およびその用途
JP3633942B2 (ja) 1998-09-09 2005-03-30 キユーピー株式会社 嘔吐予防食品
US6242035B1 (en) 1998-11-23 2001-06-05 Cp Kelco U.S., Inc. Reduced molecular weight native gellan gum
NL1013175C2 (nl) 1999-09-29 2001-03-30 Nutricia Nv Voedingssamenstellingen die niet-verteerbare polysacchariden bevatten en gebruik ervan voor het verminderen van transport door tight junctions.
US6280779B1 (en) * 1999-12-28 2001-08-28 Colgate-Palmolive Company Pet food for maintaining normal bowel health
US6410079B2 (en) * 1999-12-28 2002-06-25 Hill's Pet Nutrition, Inc. High meat pet food compositions
US6426195B1 (en) * 2000-03-28 2002-07-30 Biogenex Lab Method for silver staining a pathologic sample
JP2001269125A (ja) 2000-03-29 2001-10-02 Nihon Nosan Kogyo Kk 豚用飼料
KR100437497B1 (ko) * 2001-03-07 2004-06-25 주식회사 프로바이오닉 로타바이러스 및 유해 미생물 억제 활성을 가지는 신규내산성 락토바실러스 루테리 프로바이오-16 및 이를함유하는 생균활성제
EP1250851A1 (en) * 2001-04-18 2002-10-23 Societe Des Produits Nestle S.A. Pet food composition containing semi-refined gelling agent
NZ515869A (en) 2001-11-30 2003-09-26 Med Chem Ingredients Ltd Compositions and methods for animal treatment comprising gluco- and isomalto- oligosaccharides
JP2003210075A (ja) * 2002-01-21 2003-07-29 Nippon Flour Mills Co Ltd 釣用疑似餌、その製造方法及び釣用疑似餌の製造用キット
GB0203431D0 (en) 2002-02-13 2002-04-03 Mars Inc Gel
JP2003259817A (ja) 2002-03-08 2003-09-16 Takeo Co Ltd ペット用冷菓組成物、それを用いたペット用冷菓およびペット用冷菓の製造方法
CN1395938A (zh) * 2002-09-03 2003-02-12 林斌 一种含低聚果糖的兽用口服液制剂
US7455869B2 (en) * 2002-12-19 2008-11-25 San-Ei Gen F.F.I., Inc. Composition for preparing artificial fruit flesh and food product containing the same
US20040168951A1 (en) 2003-02-27 2004-09-02 Mackie Robert W. Method and system for self administration of medications
US20040180079A1 (en) 2003-03-12 2004-09-16 Colgate-Palmolive Company Method and composition
US20050004071A1 (en) * 2003-04-21 2005-01-06 Comper Wayne D. Charged polysaccharides resistant to lysosomal degradation during kidney filtration and renal passage and their use to treat or prevent infection by coronaviruses
CA2530843A1 (en) 2003-07-01 2005-01-20 Todd Maibach Film comprising therapeutic agents
US20050119222A1 (en) 2003-12-01 2005-06-02 The Iams Company Compositions comprising fermentable fiber which are adapted for use by a companion animal and kits and methods of their use

Also Published As

Publication number Publication date
US8685943B2 (en) 2014-04-01
BRPI0515376A (pt) 2008-07-22
CN101060861A (zh) 2007-10-24
CN101060861B (zh) 2016-06-01
EP1796728A4 (en) 2008-07-23
US20080160164A1 (en) 2008-07-03
JP2008513474A (ja) 2008-05-01
RU2563137C2 (ru) 2015-09-20
CA2581020A1 (en) 2006-03-23
AU2005284784A1 (en) 2006-03-23
WO2006032005A2 (en) 2006-03-23
AU2005284784B2 (en) 2010-12-16
RU2007114054A (ru) 2008-10-27
CN105878267A (zh) 2016-08-24
RU2010135601A (ru) 2012-02-27
US20050042260A1 (en) 2005-02-24
US8563029B2 (en) 2013-10-22
US20140171386A1 (en) 2014-06-19
EP1796728A2 (en) 2007-06-20
WO2006032005A3 (en) 2006-10-19
US9028861B2 (en) 2015-05-12
CA2581020C (en) 2016-06-14

Similar Documents

Publication Publication Date Title
ZA200703100B (en) Method and composition for preventing or treating diarrhea
PT1755391E (pt) Métodos e composições para o tratamento de neuropatias
MY143799A (en) Compositions and methods for treating diabetes
GB2423928B (en) Methods and compositions for treating pain
IL180844A0 (en) Compositions and methods for treating excessive bleeding
IL186599A0 (en) Methods for treating and preventing fibrosis
PT1771201E (pt) Composições e métodos para o tratamento ou prevenção de doenças relacionadas com oxalato
ZA200708575B (en) Methods and compositions for treating or preventing cancer
IL182337A0 (en) Method and composition for enhancing anti-angiogenic therapy
IL164219A0 (en) Method for treating and preventing hyparathyroidism
IL182537A0 (en) Metal ion-containing cmp composition and method for using the same
EP1684771A4 (en) COMPOSITION AND METHOD
IL185555A0 (en) Method and composition for treating diabetes
ZA200605722B (en) Composition and method
EP1824462A4 (en) COMPOSITION AND METHOD FOR THE TREATMENT OF TAUOPATHIES
ZA200602275B (en) Composition and method for treating bezoar and trichobezoar
EP1959982A4 (en) METHODS AND COMPOSITIONS FOR PREVENTING AND / OR TREATING PANCREATITIS
IL163878A0 (en) Compositions and methods for treating mdma-inducedtoxicity
IL182711A0 (en) Method and composition for identification
GB0519334D0 (en) Method and composition for treating skin
EP1608316A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF INFLAMMATORY CONDITIONS
EP1796712A4 (en) METHOD AND COMPOSITIONS FOR TREATING HYPERCHOLESTEROLEMIA
GB0417415D0 (en) Composition and method
GB0425737D0 (en) Composition and method
GB0426756D0 (en) Composition and method